Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials Author Name Ralph A. DeFronzo et al Category Computer science, information & general works Type Journal Tags Adverse drug event,Dipeptidyl peptidase-4 inhibitor,Drug side effects,Hypoglycemia,SGLT2 inhibitor Login to Access Content
